Correction to: De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome

Francesco Vetrini^{1

2}, Shane McKee³, Jill A Rosenfeld⁴, Mohnish Suri⁵, Andrea M Lewis⁴, Kimberly Margaret Nugent^{4

6}, Elizabeth Roeder^{4

6}, Rebecca O Littlejohn^{4

6}, Sue Holder⁷, Wenmiao Zhu¹, Joseph T Alaimo⁴, Brett Graham^{4

2}, Jill M Harris⁸, James B Gibson⁸, Matthew Pastore⁹, Kim L McBride⁹, Makanko Komara¹⁰, Lihadh Al-Gazali¹⁰, Aisha Al Shamsi¹¹, Elizabeth A Fanning¹², Klaas J Wierenga^{12

13}, Daryl A Scott^{4

14}, Ziva Ben-Neriah¹⁵, Vardiella Meiner¹⁵, Hanoch Cassuto¹⁶, Orly Elpeleg¹⁷, J Lloyd Holder Jr¹⁸, Lindsay C Burrage⁴, Laurie H Seaver¹⁹, Lionel Van Maldergem²⁰, Sonal Mahida²¹, Janet S Soul²¹, Margaret Marlatt²¹, Ludmila Matyakhina²², Julie Vogt²³, June-Anne Gold²⁴, Soo-Mi Park²⁴, Vinod Varghese²⁵, Anne K Lampe²⁶, Ajith Kumar²⁷, Melissa Lees²⁷, Muriel Holder-Espinasse²⁸, Vivienne McConnell³, Birgitta Bernhard⁷, Ed Blair²⁹, Victoria Harrison³⁰; DDD study; Donna M Muzny^{4

31}, Richard A Gibbs^{4

31}, Sarah H Elsea^{1

4}, Jennifer E Posey⁴, Weimin Bi^{1

4}, Seema Lalani^{1

4

18}, Fan Xia^{1

4}, Yaping Yang^{1

4}, Christine M Eng^{1

4}, James R Lupski^{1

4

31

18}, Pengfei Liu^{32

33}

Affiliations

¹ Baylor Genetics, Houston, TX, 77021, USA.
² Present address: Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
³ Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, UK.
⁴ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
⁵ Nottingham Genetics Service, Nottingham City Hospital, Nottingham, UK.
⁶ Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, 78207, USA.
⁷ North West Thames Regional Genetics Service, 759 Northwick Park Hospital, London, UK.
⁸ Dell Children's Medical Group, Austin, TX, 78723, USA.
⁹ Division of Genetic and Genomic Medicine, Nationwide Children's Hospital; and Department of Pediatrics, College of Medicine, Ohio State University, Columbus, OH, 43205, USA.
¹⁰ Department of Pediatrics, College of Medicine & Health Sciences, United Arab University, Al Ain, UAE.
¹¹ Department of Pediatrics, Tawam Hospital, Al-Ain, UAE.
¹² Department of Pediatrics, Section of Genetics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
¹³ Present address: Mayo Clinic Florida, Department of Clinical Genomics, Jacksonville, FL, 32224, USA.
¹⁴ Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, 77030, USA.
¹⁵ Department of Human Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
¹⁶ The Hebrew University of Jerusalem, Jerusalem, Israel.
¹⁷ Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, 91120, Jerusalem, Israel.
¹⁸ Department of Pediatrics, Texas Children's Hospital, Houston, TX, 77030, USA.
¹⁹ Department of Pediatrics, University of Hawaii, Honolulu, HI, 96826, USA.
²⁰ Centre de Génétique Humaine, Université de Franche-Comté, Besançon, France.
²¹ Department of Neurology, Boston Children's Hospital, Boston, MA, 0211, USA.
²² Gene DX, Gaithersburg, MD, 20877, USA.
²³ West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Women's and Children's Hospitals NHS Foundation Trust, Birmingham, UK.
²⁴ East Anglia Regional Genetics Service, Addenbrooke's Hospital, Cambridge, UK.
²⁵ All-Wales Medical Genetics Service, University Hospital of Wales, Cardiff, UK.
²⁶ South East of Scotland Clinical Genetic Service, Western General Hospital, Edinburgh, UK.
²⁷ North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK.
²⁸ South East Thames Regional Genetics Service, Guy's Hospital, London, UK.
²⁹ Oxford Regional Genetics Service, Oxford University Hospitals, Oxford, UK.
³⁰ Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
³¹ Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
³² Baylor Genetics, Houston, TX, 77021, USA. pengfeil@bcm.edu.
³³ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA. pengfeil@bcm.edu.

PMID: 30909959
PMCID: PMC6434874
DOI: 10.1186/s13073-019-0630-1

Published Erratum

Correction to: De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome

Francesco Vetrini et al. Genome Med. 2019.

. 2019 Mar 25;11(1):16.

doi: 10.1186/s13073-019-0630-1.

Authors

Affiliations

¹ Baylor Genetics, Houston, TX, 77021, USA.
² Present address: Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
³ Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast, UK.
⁴ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
⁵ Nottingham Genetics Service, Nottingham City Hospital, Nottingham, UK.
⁶ Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, 78207, USA.
⁷ North West Thames Regional Genetics Service, 759 Northwick Park Hospital, London, UK.
⁸ Dell Children's Medical Group, Austin, TX, 78723, USA.
⁹ Division of Genetic and Genomic Medicine, Nationwide Children's Hospital; and Department of Pediatrics, College of Medicine, Ohio State University, Columbus, OH, 43205, USA.
¹⁰ Department of Pediatrics, College of Medicine & Health Sciences, United Arab University, Al Ain, UAE.
¹¹ Department of Pediatrics, Tawam Hospital, Al-Ain, UAE.
¹² Department of Pediatrics, Section of Genetics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
¹³ Present address: Mayo Clinic Florida, Department of Clinical Genomics, Jacksonville, FL, 32224, USA.
¹⁴ Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, 77030, USA.
¹⁵ Department of Human Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
¹⁶ The Hebrew University of Jerusalem, Jerusalem, Israel.
¹⁷ Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, 91120, Jerusalem, Israel.
¹⁸ Department of Pediatrics, Texas Children's Hospital, Houston, TX, 77030, USA.
¹⁹ Department of Pediatrics, University of Hawaii, Honolulu, HI, 96826, USA.
²⁰ Centre de Génétique Humaine, Université de Franche-Comté, Besançon, France.
²¹ Department of Neurology, Boston Children's Hospital, Boston, MA, 0211, USA.
²² Gene DX, Gaithersburg, MD, 20877, USA.
²³ West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Women's and Children's Hospitals NHS Foundation Trust, Birmingham, UK.
²⁴ East Anglia Regional Genetics Service, Addenbrooke's Hospital, Cambridge, UK.
²⁵ All-Wales Medical Genetics Service, University Hospital of Wales, Cardiff, UK.
²⁶ South East of Scotland Clinical Genetic Service, Western General Hospital, Edinburgh, UK.
²⁷ North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK.
²⁸ South East Thames Regional Genetics Service, Guy's Hospital, London, UK.
²⁹ Oxford Regional Genetics Service, Oxford University Hospitals, Oxford, UK.
³⁰ Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
³¹ Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
³² Baylor Genetics, Houston, TX, 77021, USA. pengfeil@bcm.edu.
³³ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA. pengfeil@bcm.edu.

PMID: 30909959
PMCID: PMC6434874
DOI: 10.1186/s13073-019-0630-1

Abstract

It was highlighted that the original article [1] contained a typographical error in the Results section. Subject 17 was incorrectly cited as Subject 1. This Correction article shows the revised statement. The original article has been updated.

PubMed Disclaimer

Erratum for

De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F, McKee S, Rosenfeld JA, Suri M, Lewis AM, Nugent KM, Roeder E, Littlejohn RO, Holder S, Zhu W, Alaimo JT, Graham B, Harris JM, Gibson JB, Pastore M, McBride KL, Komara M, Al-Gazali L, Al Shamsi A, Fanning EA, Wierenga KJ, Scott DA, Ben-Neriah Z, Meiner V, Cassuto H, Elpeleg O, Holder JL Jr, Burrage LC, Seaver LH, Van Maldergem L, Mahida S, Soul JS, Marlatt M, Matyakhina L, Vogt J, Gold JA, Park SM, Varghese V, Lampe AK, Kumar A, Lees M, Holder-Espinasse M, McConnell V, Bernhard B, Blair E, Harrison V; DDD study; Muzny DM, Gibbs RA, Elsea SH, Posey JE, Bi W, Lalani S, Xia F, Yang Y, Eng CM, Lupski JR, Liu P. Vetrini F, et al. Genome Med. 2019 Feb 28;11(1):12. doi: 10.1186/s13073-019-0623-0. Genome Med. 2019. PMID: 30819258 Free PMC article.

References

1. Vetrini F, et al. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith–Magenis syndrome. Genome Med. 2019;11:12. doi: 10.1186/s13073-019-0623-0. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome

Affiliations

Correction to: De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome

Authors

Affiliations

Abstract

Erratum for

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources